Otorino SRL
Otorino reported total assets of €1.86m at the end of the 2025 financial year (annual accounts filed with the NBB on 02 Jul 2026).
By total assets for 2025, Otorino ranks in the top half of the 993 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Otorino shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +46 % Total assets +48 %
Accounts of the company itself (not consolidated).
The full file covers 16 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Otorino's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Jul 2026
- Year ended 31 Dec 2024filed on 23 Aug 2025
- Year ended 31 Dec 2023filed on 22 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 15 Aug 2022
Otorino's financial analysis
- Solvency89.0%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Otorino
Otorino's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0458.783.472
- VAT number
- BE0458783472
- Peppol
- Registered · 0208:0458783472 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 12 Sep 1996
- Registered office
- 1410 Waterloo
- Latest accounts
- 2025 · filed on 02 Jul 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Otorino (SRL) has been based in Waterloo since 1996, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 297,503 € and equity of €1.65m; its revenue is not published. Its solvency stands at 89.0%, above the median of its sector (58.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Otorino
Companies in the same business, of comparable size and area, outside its group.
- NanoBiotech Research and experimental development on natural sciences and engineering Diepenbeek · balance sheet 1,834 €
- E-Proteins Research and experimental development on natural sciences and engineering Gembloux · balance sheet €1.71m
- Matthys Charlotte Research and experimental development on natural sciences and engineering Aalter · balance sheet €1.65m
- ReWind Therapeutics Research and experimental development on natural sciences and engineering Leuven · balance sheet €2.09m
- Novalix Belgium Research and experimental development on natural sciences and engineering Braine-l'Alleud · balance sheet €1.64m
- Apotheker-Bioloog Dimitri Baetens Research and experimental development on natural sciences and engineering Lokeren · balance sheet €2.15m
- Sunrock Assets Belgium I Research and experimental development on natural sciences and engineering Brussels · balance sheet €2.21m
- Trim Therapeutics Research and experimental development on natural sciences and engineering Ghent · balance sheet €1.50m
Frequently asked questions about Otorino
What is the revenue of Otorino?
Otorino files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Otorino?
In Belgium, the VAT number is the company number prefixed with BE: BE0458783472 for Otorino, if the company is VAT-registered. Its company number (CBE) is 0458.783.472.
Where is the registered office of Otorino?
According to the CBE register, the registered office of Otorino is in 1410 Waterloo.
What is the equity of Otorino?
At the close of the 2025 financial year, the equity of Otorino amounts to 1,651,820 €, a solvency of 89.0% of total assets.
Who manages Otorino?
The register lists 1 active mandates at Otorino. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Otorino within its sector?
By total assets for 2025, Otorino ranks in the top half of the 993 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year.
The full file of Otorino
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →